Cyrus Therapeutics
PrivateLast Round
Series C
Nov 11, 2025
Total Funding Raised
$47.74M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cyrus Therapeutics is a biotechnology company that develops small molecule medicines and next-generation anticancer drugs targeting undruggable proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyrus Therapeutics Comparables
Compare Cyrus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pin Therapeutics | 89% | |
| Ubix Therapeutics | 87% | |
| Illimis Therapeutics | 85% | |
Cyrus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 11, 2025 | ||||
| Series B | Jan 27, 2022 | ||||
| Series A | Sep 28, 2020 |
Cyrus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paratus Investment | Series A, Series B |
| Timefolio Asset Management | Series A, Series B |
| Mirae Asset Capital | Series B |
| Kolon Investment | Series A, Series B |
| Mirae Asset Venture Investment | Series B |
| Atinum Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 39% MoM, reaching 3.9K.
- May 12, 2026
Monthly visitors increased 44% MoM.
Cyrus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cyrus Therapeutics's valuation, stock price, and market status.